Novartis ramps up US stockpiles to shield against potential tariffs

Core Viewpoint - Novartis AG has significantly increased its stockpiles of pharmaceuticals in the United States to prepare for potential tariffs [1] Company Summary - The Chief Executive Officer Vas Narasimhan indicated that the company is positioning itself strategically to withstand potential tariffs [1]